← back to search

Stefanie Hultzsch

Humboldt-Universität zu Berlin · DE
Area of research
Public Health, Environmental and Occupational Health · Obstetrics and Gynecology
Research interest
Research interests include Pregnancy and Medication Impact, Pregnancy and preeclampsia studies, Reproductive System and Pregnancy, and Inflammatory mediators and NSAID effects.
h-index
9
citations
266
works
23
NIH funding
primary concept
email

Recent publications

Fetal adverse effects following NSAID or metamizole exposure in the 2nd and 3rd trimester: an evaluation of the German Embryotox cohort
BMC Pregnancy and Childbirth 2022cited by 38position: middledoi
Can non-responding mask or mimic drug effects on pregnancy outcome? Evaluation of case characteristics based on the national Embryotox cohort
Reproductive Toxicology 2022cited by 5position: middledoi
First trimester naproxen exposure and outcome of pregnancy – A German case series
Reproductive Toxicology 2021cited by 12position: firstdoi
Risk estimation of fetal adverse effects after short-term second trimester exposure to non-steroidal anti-inflammatory drugs: a literature review
European Journal of Clinical Pharmacology 2019cited by 49position: middledoi
Negligible risk of prenatal ductus arteriosus closure or fetal renal impairment after third‐trimester paracetamol use: evaluation of the German Embryotox cohort
BJOG An International Journal of Obstetrics & Gynaecology 2019cited by 28position: middledoi
No evidence of adverse pregnancy outcome after exposure to ibuprofen in the first trimester – Evaluation of the national Embryotox cohort
Reproductive Toxicology 2018cited by 36position: middledoi
Safety of diclofenac use during early pregnancy: A prospective observational cohort study
Reproductive Toxicology 2018cited by 23position: middledoi
Exposure to cox-2 inhibitors (coxibs) during the first trimester and pregnancy outcome: a prospective observational cohort study
European Journal of Clinical Pharmacology 2017cited by 21position: middledoi
Metamizole use during first trimester—A prospective observational cohort study on pregnancy outcome
Pharmacoepidemiology and Drug Safety 2017cited by 18position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Katarina Dathe · Humboldt-Universität zu Berlin9 papers (2017–2022)Stephanie Padberg · Charité - Universitätsmedizin Berlin7 papers (2017–2022)Christof Schaefer · Humboldt-Universität zu Berlin6 papers (2017–2022)Katja Meixner · Humboldt-Universität zu Berlin5 papers (2017–2019) · 5 papers (2017–2019)Evelin Beck · Humboldt-Universität zu Berlin4 papers (2017–2022)Tatjana Tissen‐Diabaté · Charité - Universitätsmedizin Berlin3 papers (2017–2018)Anne‐Katrin Fietz · Zimmer Biomet (Netherlands)3 papers (2017–2021)Christof Schaefer · Humboldt-Universität zu Berlin3 papers (2017–2018)Lucas William Pritchard · Humboldt-Universität zu Berlin2 papers (2018–2019)Verena Linsenmeier · Humboldt-Universität zu Berlin1 papers (2018–2018)Regina Stegherr · Humboldt-Universität zu Berlin1 papers (2022–2022)Luisa-Maria Köhler · Humboldt-Universität zu Berlin1 papers (2017–2017)J Frank · Momentive (United States)1 papers (2019–2019)Johanna Frank · Humboldt-Universität zu Berlin1 papers (2022–2022) · 1 papers (2021–2021)